samedan logo
 
 
spacer
home > ebr > spring 2002 > polymer substrate for dna microarrays
PUBLICATIONS
European BioPharmaceutical Review

Polymer Substrate for DNA Microarrays

Microarray technology - allowing the massive parallel profiling of gene expression in a single hybridisation experiment - has gained acceptance as a powerful molecular genetic tool for biomedical research. Historically, gene analysis was performed through immobilisation of DNA probes on supports such as nylon membrane or nitrocellulose, allowing their hybridisation to radioactivity labelled complementary sequences. However, the increasing sequence data derived from the genome projects has prompted the automation of array production and demanded more practical support for large-scale genome studies.A number of different substrates have been tested as solid supports for nucleic acid immobilisation. For several reasons, glass became the favourite choice within the microarray technology because its non-porosity liquid cannot penetrate the surface. This speeds up the kinetics of hybridisation by keeping the hybridisation volume small. It is a durable material and has great chemical resistance so that robust chemistries can be used for a covalent binding of oligonucleotides to the surface. Furthermore, glass has low intrinsic fluorescence properties which improves the signal to noise ratio when high intensity lasers are focused on the surface.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Tina Kristensen, Research Scientist at NUNC A/S

Tina Kristensen is a Research Scientist at NUNC A/S in Denmark. She joined NUNC in 1999 and her work is centred on molecular biology, with a particular focus on polymer slides for microarray applications. Tina holds a PhD in Molecular Biology from the University of Roskilde, Denmark.

spacer
Tina Kristensen
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

Clinical Trials in CNS

25-26 November 2008, Copthorne Tara Hotel, London, UK

SMi present their 7th annual conference… Clinical Trials in CNS 25th to 26th November 2008, Copthorne Tara Hotel, London, UK
More info >>

 
News and Press Releases

Azopharma Product Development Group, Inc

HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement